Français
ItalianoBond Pfizer 5.3% ( US716973AG71 ) in USD
| Issuer | Pfizer | ||||||
| Market price |  95.76 % ▲ |
||||||
| Country |  United States
|
||||||
| ISIN code |
 US716973AG71 ( in USD )
|
||||||
| Interest rate | 5.3% per year ( payment 2 times a year) | ||||||
| Maturity | 19/05/2053 | ||||||
|
Prospectus brochure in PDF format |
|||||||
| Minimal amount | / | ||||||
| Total amount | / | ||||||
| Cusip | 716973AG7 | ||||||
| Standard & Poor's ( S&P ) rating | A ( Upper medium grade - Investment-grade ) | ||||||
| Moody's rating | A2 ( Upper medium grade - Investment-grade ) | ||||||
| Next Coupon | 19/11/2026 ( In 87 days ) | ||||||
| Detailed description |
Pfizer is a multinational pharmaceutical and biotechnology company headquartered in New York City that researches, develops, manufactures, and markets drugs and vaccines globally. The Bond issued by Pfizer ( United States ) , in USD, with the ISIN code US716973AG71, pays a coupon of 5.3% per year. The coupons are paid 2 times per year and the Bond maturity is 19/05/2053 The Bond issued by Pfizer ( United States ) , in USD, with the ISIN code US716973AG71, was rated A2 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Pfizer ( United States ) , in USD, with the ISIN code US716973AG71, was rated A ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||
| |||||||